Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis

PURPOSE: Our purpose was to explore the prognosis of aggressive breast cancers of the HER2 oncogene amplification (HER2 +) and triple-negative (TN) subtypes detected by screening, as well as the prognosis of interval cancers (clinically due to symptoms between screening rounds) and cancers in screen...

Descripción completa

Detalles Bibliográficos
Autores principales: Alanko, Johanna, Tanner, Minna, Vanninen, Ritva, Auvinen, Anssi, Isola, Jorma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062374/
https://www.ncbi.nlm.nih.gov/pubmed/33420595
http://dx.doi.org/10.1007/s10549-020-06060-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062374/
https://www.ncbi.nlm.nih.gov/pubmed/33420595
http://dx.doi.org/10.1007/s10549-020-06060-z

Ejemplares similares